BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11786180)

  • 1. Individuation of monoclonal anti-HPV16 E7 antibody linear peptide epitope by computational biology.
    Kanduc D; Lucchese A; Mittelman A
    Peptides; 2001 Dec; 22(12):1981-5. PubMed ID: 11786180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope.
    Kanduc D; Fanizzi FP; Lucchese G; Stevanovic S; Sinha AA; Mittelman A
    Peptides; 2004 Feb; 25(2):243-50. PubMed ID: 15063005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity.
    Tiwari R; Geliebter J; Lucchese A; Mittelman A; Kanduc D
    Peptides; 2004 Nov; 25(11):1865-71. PubMed ID: 15501517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal and polyclonal humoral immune response to EC HER-2/NEU peptides with low similarity to the host's proteome.
    Mittelman A; Lucchese A; Sinha AA; Kanduc D
    Int J Cancer; 2002 Apr; 98(5):741-7. PubMed ID: 11920645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of MHC II affinity and molecular mimicry in defining anti-HER-2/neu MAb-3 linear peptide epitope.
    Lucchese A; Stevanovic S; Sinha AA; Mittelman A; Kanduc D
    Peptides; 2003 Feb; 24(2):193-7. PubMed ID: 12668202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.
    van der Burg SH; Ressing ME; Kwappenberg KM; de Jong A; Straathof K; de Jong J; Geluk A; van Meijgaarden KE; Franken KL; Ottenhoff TH; Fleuren GJ; Kenter G; Melief CJ; Offringa R
    Int J Cancer; 2001 Mar; 91(5):612-8. PubMed ID: 11267969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage display for site-specific immunization and characterization of high-risk human papillomavirus specific E7 monoclonal antibodies.
    Lidqvist M; Nilsson O; Holmgren J; Hall C; Fermér C
    J Immunol Methods; 2008 Sep; 337(2):88-96. PubMed ID: 18606164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of H-2Kb binding and immunogenic peptides from human papilloma virus tumour antigens E6 and E7.
    Bauer S; Heeg K; Wagner H; Lipford GB
    Scand J Immunol; 1995 Sep; 42(3):317-23. PubMed ID: 7660065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular specificity of linear B-epitopes in the E7 open reading frame protein of human papillomavirus 16 defined by monoclonal antibodies.
    Tindle RW; Zhou WD; Saul A; Frazer IH
    Pept Res; 1990; 3(4):162-6. PubMed ID: 1724617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16.
    Azoury-Ziadeh R; Herd K; Fernando GJ; Frazer IH; Tindle RW
    Viral Immunol; 1999; 12(4):297-312. PubMed ID: 10630789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants.
    Tindle RW; Croft S; Herd K; Malcolm K; Geczy AF; Stewart T; Fernando GJ
    Clin Exp Immunol; 1995 Aug; 101(2):265-71. PubMed ID: 7544248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein.
    Sadovnikova E; Zhu X; Collins SM; Zhou J; Vousden K; Crawford L; Beverley P; Stauss HJ
    Int Immunol; 1994 Feb; 6(2):289-96. PubMed ID: 7512375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences.
    Natale C; Giannini T; Lucchese A; Kanduc D
    Immunol Cell Biol; 2000 Dec; 78(6):580-5. PubMed ID: 11114967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of monoclonal antibodies against the E6 and E7 oncoproteins of HPV.
    Wlazlo AP; Giles-Davis W; Clements A; Struble G; Marmorstein R; Ertl HC
    Hybridoma; 2001 Aug; 20(4):257-63. PubMed ID: 11604112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16.
    Khammanivong V; Liu XS; Liu WJ; Rodda SJ; Leggatt GR; Tindle RW; Frazer IH; Fernando GJ
    Immunol Cell Biol; 2003 Feb; 81(1):1-7. PubMed ID: 12534940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes.
    Tindle RW; Fernando GJ; Sterling JC; Frazer IH
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5887-91. PubMed ID: 1712110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.
    Ressing ME; Sette A; Brandt RM; Ruppert J; Wentworth PA; Hartman M; Oseroff C; Grey HM; Melief CJ; Kast WM
    J Immunol; 1995 Jun; 154(11):5934-43. PubMed ID: 7538538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes.
    Pumpens P; Razanskas R; Pushko P; Renhof R; Gusars I; Skrastina D; Ose V; Borisova G; Sominskaya I; Petrovskis I; Jansons J; Sasnauskas K
    Intervirology; 2002; 45(1):24-32. PubMed ID: 11937768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential antitumor applications of a monoclonal antibody specifically targeting human papilloma virus 16 E7 49-57 peptide.
    Lei J; Zhang G
    Microbiol Immunol; 2012 Jul; 56(7):456-62. PubMed ID: 22469208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma.
    Ressing ME; de Jong JH; Brandt RM; Drijfhout JW; Benckhuijsen WE; Schreuder GM; Offringa R; Kast WM; Melief CJ
    Eur J Immunol; 1999 Apr; 29(4):1292-303. PubMed ID: 10229097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.